Multiomics data integration with machine learning has become the standard approach for combining genomic, transcriptomic, proteomic, and metabolomic measurements collected from the same biological ...
Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...
Artificial intelligence (AI) in research histopathology is turning whole-slide images of preclinical tissue into structured, quantitative data rather than a pathologist's subjective impression alone.
One of the biggest myths around artificial intelligence is that it can simply create a new medicine on its own. That is not ...
Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced the publication of new data in JAMA Oncology, evaluating the utility of Signatera, its personalized molecular ...
A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision ...
General purpose AI tools for science, such as Claude Science, promise to accelerate research. But which is right for you?
There is currently a serious outbreak in the Democratic Republic of the Congo of the severe and often fatal illness. Symptoms ...
The tools may help address underdiagnosis in this area, though there is still room for improvement in screening performance.
Looking ahead to 2030, our model projects QS could trade at an average price of $9.10, with a potential range between $6.82 and $11.37. This represents a potential 31.0% return from today's price.
Respiratory diseases continue to represent a major global health burden, ranking among the leading causes of morbidity and mortality. They encompass a wide ...
Looking ahead to 2030, our model projects NTSK could trade at an average price of $35.77, with a potential range between $26.82 and $44.71. This represents a potential 188.0% return from today's price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results